(PDF) P1.01-43 Next-Generation Sequencing in the

P1.01-43 Next-Generation Sequencing in the Exploration of Genetic Heterogeneity for Lung Adenocarcinoma Patients With EGFR Activating Mutations

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.599

Full Text

Open PDF

Abstract

Available in full text

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

Mutation Profile of Resected EGFR‐Mutated Lung Adenocarcinoma by Next‐Generation Sequencing

English

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

Pathology and Oncology Research

English

Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations

Experimental and Therapeutic Medicine

English

Next-Generation Sequencing and Clinical Outcomes of Patients With Lung Adenocarcinoma Treated With Stereotactic Body Radiotherapy

English

Next Generation Sequencing a Method for Identifying Genetic Mutations Associated With Spina Bifida Disorder

Pajouhan Scientific Journal

2019

English

P1.13-14 the Molecular Landscape of Lung Adenocarcinomas With Activating EGFR Gene Mutations Determined by Targeted-Sequencing

Journal of Thoracic Oncology

English

P1.01-85 the Prevalence of Different EGFR Exon20 Mutations in 12,833 Chinese Lung Cancer Patients

Journal of Thoracic Oncology

English

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

English

A Targeted Next-Generation Sequencing Method for Identifying Clinically Relevant Mutation Profiles in Lung Adenocarcinoma

Scientific Reports

Multidisciplinary

2016

English

Amanote Research

P1.01-43 Next-Generation Sequencing in the Exploration of Genetic Heterogeneity for Lung Adenocarcinoma Patients With EGFR Activating Mutations

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.599

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Mutation Profile of Resected EGFR‐Mutated Lung Adenocarcinoma by Next‐Generation Sequencing

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations

Next-Generation Sequencing and Clinical Outcomes of Patients With Lung Adenocarcinoma Treated With Stereotactic Body Radiotherapy

Next Generation Sequencing a Method for Identifying Genetic Mutations Associated With Spina Bifida Disorder

P1.13-14 the Molecular Landscape of Lung Adenocarcinomas With Activating EGFR Gene Mutations Determined by Targeted-Sequencing

P1.01-85 the Prevalence of Different EGFR Exon20 Mutations in 12,833 Chinese Lung Cancer Patients

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

A Targeted Next-Generation Sequencing Method for Identifying Clinically Relevant Mutation Profiles in Lung Adenocarcinoma